MRVL.V - Marvel Biosciences Corp.

TSXV - TSXV Real Time Price. Currency in CAD
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
7/31/2022
7/31/2021
7/31/2020
Total Revenue
0
0
0
0
Cost of Revenue
1,145
1,377
613.099
265.2
Gross Profit
-1,145
-1,377
-613.099
-265.2
Operating Expense
1,182
1,171
485.043
689.571
Operating Income
-2,327
-2,548
-1,098
-954.771
Net Non Operating Interest Income Expense
-3.214
-1.549
-1.729
-0.316
Other Income Expense
-7.827
-4.311
-1,939
-0.57
Pretax Income
-2,340
-2,554
-3,039
-955.657
Net Income Common Stockholders
-2,340
-2,554
-3,039
-955.657
Diluted NI Available to Com Stockholders
-2,340
-2,554
-3,039
-955.657
Basic EPS
-
-0.08
-0.17
-0.03
Diluted EPS
-
-0.08
-0.17
-0.03
Basic Average Shares
-
32,759
17,697
32,586
Diluted Average Shares
-
32,759
17,697
32,586
Total Expenses
2,327
2,548
1,098
954.771
Net Income from Continuing & Discontinued Operation
-2,340
-2,554
-3,039
-955.657
Normalized Income
-2,330
-2,550
-1,135
-955.087
Interest Income
-
0
0.239
0.403
Net Interest Income
-3.214
-1.549
-1.729
-0.316
EBIT
-2,327
-2,548
-1,098
-954.771
EBITDA
-2,327
-
-
-
Reconciled Cost of Revenue
1,145
1,377
613.099
265.2
Reconciled Depreciation
0.114
0.152
0.185
0.413
Net Income from Continuing Operation Net Minority Interest
-2,340
-2,554
-3,039
-955.657
Total Unusual Items Excluding Goodwill
-9.931
-4.311
-1,904
-0.57
Total Unusual Items
-9.931
-4.311
-1,904
-0.57
Normalized EBITDA
-2,317
-2,544
806.518
-953.788
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0

Yahoo Finance Plus Essential access required.

Learn more